---
layout: archive
title: "Resources"
permalink: /resources/
author_profile: true
---


## Causality and Program Evaluation


- [Differences-in-Difference design, Health Care Policy Science Lab](https://diff.healthpolicydatascience.org/)

- [Methods Articles Health Care Policy Science Lab](http://healthpolicydatascience.org/methods-seminar)

- [Hernán MA, Robins JM. Causal Inference: What If.](https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/)

- [Causal Inference: The Mixtape](https://scunning.com/mixtape.html), by Scott Cunningham

- [Causal Graphs](http://www.nickchk.com/causalgraphs.html) explained by Nick Huntington Klein helps to gain an intuitive understanding of identifying causal effects from non-experimental data, [more resources provided](http://www.nickchk.com/causalitybook.html)



## Social science research methods

- [Health Services Research methods corner](https://www.hsr.org/methods-corner-article-collection) provides many resources for program evaluation, econometrics and qualitative research

## Reproducible research & open science

- A guide to [Reproducibility in Science](http://ropensci.github.io/reproducibility-guide/)

- [The Open Science Training Handbook](https://book.fosteropenscience.eu/en/)

- [Data and Code Guidance by Data Editors](https://social-science-data-editors.github.io/guidance/Requested_information.html)

- Uri Simonshon caters [8 tips to make open research more findable and accessible](http://datacolada.org/69)

- Michael Shill provides [tips to produce legible and reprodrucible do-files in Stata](https://michaelshill.net/2015/07/31/in-stata-coding-style-is-the-essential/)

- Cornell University caters [a guide to generate a Readme file](https://data.research.cornell.edu/content/readme) to document the meta data of a project.

- - -



## Data - Pharmaceutical markets

### Pharmaceutical reference data bases

These data bases help to identify active ingredients by different classifications, all of which are **freely** available.

- [WHO ATC Index](https://www.whocc.no/atc_ddd_index/) helps to find active pharmaceutical ingredients by the ATC classification

- [German ATC Index](https://www.dimdi.de/dynamic/en/drugs/atc-classification/index.html)

- [Drugbank.com](https://www.drugbank.com/) allows finding and classifying drugs by a large variety of criteria including the ATC classification, marketing authorization data for the United States (FDA), Canada and the European Union (EMA), a public use file is available for download if you register your research project.

- [DrugCentral](https://drugcentral.org/download) provides comprehensive data about chemical and pharmacological features of pharmaceuticals as well as marketing authorization data.

- [RxNorm](https://www.nlm.nih.gov/research/umls/rxnorm/index.html) is the US National Library's compedium linking different vocabularies that document drugs. You may browse it via [RxNav](https://mor.nlm.nih.gov/RxNav/)

- [Swiss Pharmaceutical Reference Database - Spezialitätenliste](), is freely available for download

- German pharmaceutical reference databases are behind paywalls, or for scientific research use that requires registration of a research project

	- [WIDO GKV Arzneimittelindex / German Drug Index](https://www.gbe-bund.de/gbe/ergebnisse.prc_tab?fid=8325&suchstring=arzneiverordnungsreport&query_id=&sprache=E&fund_typ=DQM&methode=&vt=&verwandte=1&page_ret=0&seite=1&p_sprachkz=E&p_uid=&p_lfd_nr=&p_news=&p_aid=&hlp_nr=&p_janein=)
	- [ABDATA Pharma Daten Service](https://abdata.de/)

### Drug shortages

- [Drug shortages in Switzerland provided by Enea Martinelli](drugshortage.ch)


### HTA and value based decision-making

- Early assessments of health benefit based on AMNOG ([Arzneimittelmarktneuordnungsgesetz](https://www.g-ba.de/bewertungsverfahren/nutzenbewertung/)) in Germany

    - Comprehensive data of benefit assessments is [provided in XML format from GBA](https://www.g-ba.de/themen/arzneimittel/arzneimittel-richtlinie-anlagen/nutzenbewertung-35a/ais/), currently includes decisions starting from 2020, but will be updated steadily to cover all assessments starting from 2011.
	- [As part of a project funded by the German Research Foundation, I provide data from the first years that AMNOG was in effect](https://www.hcm.wiwi.uni-due.de/en/research-projects/early-benefit-assessment-of-innovative-pharmaceuticals-according-to-amnog-in-germany-empirical-analysis-of-the-decision-making-process/)
	- [DAK AMNOG Report 2020](https://www.dak.de/dak/bundesthemen/dak-amnog-report-2020-2331046.html#/), annual report of AMNOG decisions
	- [Innovationsreport Techniker Krankenkasse](https://www.tk.de/leistungserbringer/personengruppen/aerzte/innovationsreport-2059108) is an annual report about the quality of pharmaceutical care

- - -

### Pharmaceutical market in Germany - all resources are in *German only*

- [Zi Trendbericht provides developments of prescription pharmaceuticals in Germany](https://www.zi.de/projekte/rx-trendbericht)

- [Arzneiverordnungsreport](https://www.wido.de/publikationen-produkte/buchreihen/arzneiverordnungs-report/?L=0) is the annual report of the Germany pharmaceutical market based on GKV-Arzneimittelindex für ambulante Patienten (*Statutory Health Insurance Pharmaceutical Index for patients in ambulatory care*), provided by AOK-Bundesverband, see the [2020 Edition here](http://link.springer.com/10.1007/978-3-662-62168-4).

- [Barmer Krankenkasse provides an annual report of the pharmaceutical market](https://www.barmer.de/presse/infothek/studien-und-reports/arzneimittelreporte)

- [WIP provides a report for pharmaceutical care in the privately insured](http://www.wip-pkv.de/forschungsbereiche/detail/arzneimittelversorgung-von-privatversicherten-2020-zahlen-analysen-gkv-pkv-vergleich.html)

- [Reference Prices - Festbeträge](https://www.dimdi.de/dynamic/de/arzneimittel/festbetraege-und-zuzahlungen/arzneimittel-festbetraege/)



- - -

## Data - Physicians

- [US National Ambulatory Medical Care Survey (NAMCS)](https://www.cdc.gov/nchs/ahcd/index.htm) has public use files on physician level
